Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Irani

Showing results (101-110 of 103) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 103 results.
Journal of Virology|July 18, 2014
Novel indole-2-carboxamide compounds are potent broad-spectrum antivirals active against western equine encephalitis virus in vivoPhillip C Delekta, Craig J Dobry, Janice A Sindac, et al.
The Journal of Biological Chemistry|November 26, 2015
Loss of the Ubiquitin-conjugating Enzyme UBE2W Results in Susceptibility to Early Postnatal Lethality and Defects in Skin, Immune, and Male Reproductive SystemsBo Wang, Sean A Merillat, Michael Vincent, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2025
Engineered immunological niche directs therapeutic development in models of progressive multiple sclerosisLaila M Rad, Kevin R Hughes, Sydney N Wheeler, et al.
Pageof 11

Showing results (101-110 of 103) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 103 results.
Journal of Virology|July 18, 2014
Novel indole-2-carboxamide compounds are potent broad-spectrum antivirals active against western equine encephalitis virus in vivoPhillip C Delekta, Craig J Dobry, Janice A Sindac, et al.
The Journal of Biological Chemistry|November 26, 2015
Loss of the Ubiquitin-conjugating Enzyme UBE2W Results in Susceptibility to Early Postnatal Lethality and Defects in Skin, Immune, and Male Reproductive SystemsBo Wang, Sean A Merillat, Michael Vincent, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2025
Engineered immunological niche directs therapeutic development in models of progressive multiple sclerosisLaila M Rad, Kevin R Hughes, Sydney N Wheeler, et al.
Pageof 11